VYYRF (Voyageur Pharmaceuticals) Total Assets: $2.16 Mil (As of Feb. 2026)


VYYRF Voyageur Pharmaceuticals Ltd VYYRF
18 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals Total Assets?

Voyageur Pharmaceuticals VYYRF 18 Total Assets is $2.16 Mil as of Feb. 2026. GuruFocus rates VYYRF with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

Voyageur Pharmaceuticals's Total Assets for the quarter that ended in Feb. 2026 was $2.16 Mil.

During the past 12 months, Voyageur Pharmaceuticals's average Total Assets Growth Rate was 14.10% per year. During the past 3 years, the average Total Assets Growth Rate was 11.20% per year. During the past 5 years, the average Total Assets Growth Rate was 15.50% per year.

During the past 13 years, Voyageur Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 503.70%. The lowest was 10.50%. And the median was 15.20%.

Total Assets is connected with ROA %. Voyageur Pharmaceuticals's annualized ROA % for the quarter that ended in Feb. 2026 was -84.03%. Total Assets is also linked to Revenue through Asset Turnover. Voyageur Pharmaceuticals's Asset Turnover for the quarter that ended in Feb. 2026 was 0.01.

Voyageur Pharmaceuticals  (OTCPK:VYYRF) Total Assets Explanation

Total Assets is connected with ROA %.

Voyageur Pharmaceuticals's annualized ROA % for the quarter that ended in Feb. 2026 is

ROA %=Net Income (Q: Feb. 2026 )/( (Total Assets (Q: Nov. 2025 )+Total Assets (Q: Feb. 2026 ))/ count )
=-1.836/( (2.209+2.161)/ 2 )
=-1.836/2.185
=-84.03 %

Note: The Net Income data used here is four times the quarterly (Feb. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Voyageur Pharmaceuticals's Asset Turnover for the quarter that ended in Feb. 2026 is

Asset Turnover
=Revenue (Q: Feb. 2026 )/( (Total Assets (Q: Nov. 2025 )+Total Assets (Q: Feb. 2026 ))/ count )
=0.014/( (2.209+2.161)/ 2 )
=0.014/2.185
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Voyageur Pharmaceuticals Total Assets Related Terms

Voyageur Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals Total Assets Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.04 1.56 1.58 1.86 2.21

Voyageur Pharmaceuticals Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.21 2.13 2.67 2.21 2.16
VYYRF
18GF Score
Voyageur Pharmaceuticals Ltd VYYRF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Voyageur Pharmaceuticals's Total Assets for the fiscal year that ended in Nov. 2025 is calculated as

Total Assets=Total Equity (A: Nov. 2025 )+Total Liabilities (A: Nov. 2025 )
=0.891+1.318
=2.21

Voyageur Pharmaceuticals's Total Assets for the quarter that ended in Feb. 2026 is calculated as

Total Assets=Total Equity (Q: Feb. 2026 )+Total Liabilities (Q: Feb. 2026 )
=0.484+1.676
=2.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $2.16 Mil mean?
Voyageur Pharmaceuticals (VYYRF) has a Total Assets of $2.16 Mil as of Feb. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Voyageur Pharmaceuticals and its competitors.
Is Voyageur Pharmaceuticals' Total Assets too high?
Voyageur Pharmaceuticals' current Total Assets is $2.16 Mil. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' Total Assets compare to ZTS and UTHR?
Voyageur Pharmaceuticals' Total Assets of $2.16 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Voyageur Pharmaceuticals and its competitors. Voyageur Pharmaceuticals's current Total Assets is $2.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current Total Assets of $2.16 Mil. The current Total Assets is $2.16 Mil. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current Total Assets is $2.16 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score

Get the complete analysis for VYYRF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price